What are the potential harms/burdens of CV risk assessment screenings more than every five years?
Excessive monitoring may lead to unnecessary testing and/or treatments, resulting in the unnecessary use of medical resources, increased costs, and a lack of patient participation in check-ups. Furthermore, there is a paucity of evidence about the optimal timing and frequency for CV risk assessment in specific subgroups of patients, such as those of different ages, ethnicities, and with comorbidities, and its effect on critical outcomes such as CV mortality.